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Abstract
Background: High-sensitivity C-reactive protein (hsCRP) is associated with metabolic risk, however it is unclear
whether the relationship is confounded by racial/ethnic differences in socioeconomic status (SES), lifestyle factors
or central adiposity. The aims of the study was, (1) to investigate whether hsCRP levels differ by race/ethnicity; (2)
to examine the race/ethnic-specific associations between hsCRP, HOMA-IR and serum lipids [total cholesterol (TC),
triglycerides (TG), high-density lipoproteins (HDL-C) and low-density lipoproteins (LDL-C)]; and (3) to determine
whether race/ethnic-specific associations are explained by SES, lifestyle factors or waist circumference (WC).
Methods: The convenience sample comprised 195 black and 153 white apparently health women, aged 18–
45 years. SES (education, assets and housing density) and lifestyle factors (alcohol use, physical activity and
contraceptive use) were collected by questionnaire. Weight, height and WC were measured, and fasting
blood samples collected for hsCRP, glucose, insulin, and lipids.
Results: Black women had higher age- and BMI-adjusted hsCRP levels than white women (p = 0.047). hsCRP
was associated with HOMA-IR (p < 0.001), TG (p < 0.001), TC (p < 0.05), HDL-C (p < 0.05), and LDL-C (p < 0.05),
independent of age and race/ethnicity. The association between hsCRP and lipids differed by race/ethnicity,
such that hsCRP was positively associated with TG and LDL-C in white women, and inversely associated
with HDL-C in black women. Higher hsCRP was also associated with higher TC in white women and lower
TC in black women. Furthermore, when adjusting for SES and lifestyle factors, the associations between
hsCRP, and TC and TG, remained, however the associations between hsCRP, and HDL-C and LDL-C, were no
longer significant.
Conclusion: Although circulating hsCRP may identify individuals at increased metabolic risk, the heterogeneity in
these associations between racial/ethnic groups highlights the need for prospective studies investigating the role of
hsCRP for risk prediction in different populations.
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Background
The prevalence and incidence of non-communicable dis-
eases (NCDs), such as type 2 diabetes (T2D) and cardio-
vascular disease (CVD), are different for black and white
women. Several studies and global reports have shown
that T2D disproportionately burdens black women [1,
2], while CVD is more prevalent amongst white women
[3]. Obesity and central body fat is linked to increased
metabolic risk, including insulin resistance and elevated
serum lipid levels [4]. Indeed, visceral adipose tissue
(VAT) is associated with a greater risk of metabolic com-
plications [5, 6]. However, for the same level of body fat-
ness, black women have less VAT than white women [5,
6], have a lower prevalence of the metabolic syndrome
[7, 8] due to their more “favourable” lipid profile [7, 9],
but are more insulin resistant than white women [10,
11]. The reason for this paradox may be that different
racial/ethnic groups have a different inflammatory re-
sponse to obesity and that the differential effects of body
fat and body fat distribution on metabolic risk may be
partially mediated via inflammatory pathways [12].
C-reactive protein (CRP), an acute-phase protein se-
creted by the liver in response to interleukin-6 (IL-6)
and tumor necrosis factor (TNF)-α [13], is a well-
characterized marker of inflammation, and increased cir-
culating levels have been shown to be associated with
obesity and increased metabolic risk [14]. Interestingly,
marked racial/ethnic differences in high-sensitivity CRP
(hsCRP) concentrations have been reported, with black
women having higher levels compared to white women,
independent of adiposity [4, 12, 15]. These findings are
however not consistent, as some studies do not show ra-
cial/ethnic differences in hsCRP levels after adjusting for
body fat [16, 17]. In addition to the racial/ethnic differ-
ences in adiposity, inflammation and metabolic risk,
there are inherent racial/ethnic differences in socioeco-
nomic status (SES) and lifestyle factors, which also influ-
ence metabolic risk and outcome [18]. Indeed, studies
have shown that lower SES is associated with a higher
inflammatory profile [19, 20], possibly due to negative
health behaviours, as well as a higher prevalence of
NCDs, including T2D and CVD [21, 22]. Currently, it is
not known whether the association between hsCRP
levels and metabolic risk factors for T2D and CVD differ
between black and white South African women, and
whether SES and lifestyle factors influence the associ-
ation, or whether the relationship may be explained by
racial/ethnic differences in central adiposity.
Accordingly, the aims of this study were, 1) to investi-
gate whether hsCRP levels differ by race/ethnicity in
South African women; 2) to examine the race/ethnic-
specific associations between hsCRP, insulin resistance
(HOMA-IR) and serum lipids (total cholesterol (TC), tri-
glycerides (TG), high-density lipoproteins (HDL-C) and
low-density lipoproteins (LDL-C)); and 3) to determine
whether the race/ethnic-specific associations between
hsCRP and the metabolic risk factors may be explained
by differences in SES, lifestyle factors and/or central adi-
posity between black and white South African women.
Methods
Participants
This cross-sectional study consisted of a convenience
sample of 194 black and 153 white apparently healthy,
premenopausal, South African women, as previously de-
scribed [23]. Race/ethnicity was self-reported. Partici-
pants were recruited from church groups, community
centers and universities, in urban settings around Cape
Town, South Africa. Women were included in the study
if they were between 18 and 45 years of age, with no
known diseases and not taking medication that may alter
metabolism, were not currently pregnant, lactating or
postmenopausal (self-reported). Women with hsCRP >
10 μg/ml (n = 59) were also excluded from the study, as
this can be indicative of acute inflammation.
Approval was obtained from the Health Sciences Re-
search Ethics Committee of the University of Cape Town
and written informed consent was obtained from all sub-
jects prior to participation.
Socio-economic status and lifestyle factors
A questionnaire was administered that included measures
of SES, lifestyle factors and family history of disease [24].
Three indicators of SES were assessed, namely, level of
education, number of assets per household (asset index)
and housing density. Level of education was categorized
as not completed high school, completed high school and
post-high school (tertiary) education. The asset index
score was based on indoor access to running water and/or
flushing toilet, electricity and ownership of 12 household
amenities, which included a television, radio, motor ve-
hicle, fridge, oven/stove, washing machine, telephone,
video machine, microwave, computer, cellular telephone
and paid television channels (e.g. DSTV). Housing density
was calculated as the number of persons per household
divided by the number of rooms in the household. Partici-
pants were classified as non-smokers, if they had never
smoked, ex-smokers if they were smokers but stopped
smoking prior to the time of the interview, and current
smokers if they smoked more than 1 cigarette per day at
the time of the interview. Alcohol consumption was based
on an average weekly intake of alcohol and participants
were categorized as a non-drinker if they did not consume
any alcohol, a moderate drinker if they consumed ≤7
drinks/week (≤1 drink/day), and a heavy drinker if they
consumed > 7 drinks/week. Physical activity levels were
determined using the Global Physical Activity Question-
naire (GPAQ) [25], and moderate-to-vigorous intensity
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physical activity ≥150 min/week was categorized as suffi-
ciently active and moderate-to-vigorous intensity physical
activity < 150 min/week was categorized as insufficiently
active. Contraceptive use was self-reported and was cate-
gorized as none, oral contraceptives or injectable contra-
ceptives. Participants were also asked whether they had a
family history of T2D and/or CVD.
Anthropometry and blood pressure measures
Standard anthropometric procedures [26] were used to
measure weight, height and waist circumference (WC),
measured at the level of the umbilicus. Blood pressure
measurements were taken in a seated position after
5 min of seated rest. The systolic and diastolic blood
pressure (SBP and DBP, respectively) were recorded
three times at 1-min intervals, using an appropriately
sized cuff and an automated blood pressure monitor
(Omron 711, Omron Health Care, Hamburg, Germany).
An average of the last two readings was used in the
analyses.
Biochemical analysis
Blood samples were drawn after an overnight fast (10–
12 h) for plasma glucose, determined by the glucose
oxidase method (Glucose Analyzer 2, Beckman Instru-
ments, Fullerton, CA, USA), serum insulin, determined
by a Microparticle Enzyme Immunoassay (MEIA)
(AxSym Insulin Kit, Abbot, IL, USA), TC, HDL-C, and
TG, analyzed using the Roche Modular auto analyzer
and enzymatic colorimetric assays, and LDL-C
calculated using the Friedewald formula [27]. Homeo-
static model assessment (HOMA-IR) was estimated
from fasting insulin and glucose levels as previously de-
scribed [28]. Serum concentrations of hsCRP (Immun
Diagnostik AG, Bensheim, Germany) were analyzed
using commercially available ELISA kits according to the
manufacturer’s protocols.
Statistical analysis
All statistical analyses were performed using STATA
version 13 (Statcorp, College Station, TX) and statistical
significance was based on a p-value < 0.05. Normally
distributed data are presented as mean ± standard devi-
ation (SD) and skewed variables, as median and inter-
quartile range (IQR). Racial/ethnic differences in SES
and lifestyle factors, anthropometry and metabolic risk
factors were compared using chi-squared analysis for
categorical variables, and Student-t test and Wilcoxon
rank-sum test for normally and not normally distributed
continuous variables, respectively. Analysis of covariance
(ANCOVA), adjusting for age and BMI, was used to
compare means of serum-associated metabolic risk fac-
tors (HOMA-IR, TG, TC, HDL-C and LDL-C) between
black and white women. The non-normally distributed
metabolic risk factors were logarithmically transformed
and Pearson correlation analysis (continuous variables)
and ANOVA (categorical variables) were used to deter-
mine which SES and lifestyle factors were significantly
associated with the different metabolic risk factors (out-
come variables). Based on the results of these bivariate
associations (data not shown), multivariate linear regres-
sion analyses were used to examine the associations be-
tween hsCRP and the metabolic risk factors, with the
following models: Model 1: age + race/ethnicity + inter-
action term (interaction between race/ethnicity and
hsCRP); Model 2: Model 1 + SES and lifestyle factors;
Model 3: Model 2 +WC.
Results
Participant characteristics
The general characteristics of the study population are
presented in Table 1 and the age and BMI-adjusted blood-
based metabolic risk factors are presented in Table 2.
Black women were younger (24 vs. 31 years; p < 0.0001)
and had a higher BMI (30.4 vs 24.5 kg/m2; p = 0.0003)
than white women. Of the total sample, 55.2% of the black
women and 44.4% of the white women were overweight
or obese (BMI ≥25 kg/m2). Although there was no
significant difference in plasma glucose concentrations
between the racial/ethnic groups, black women had
higher serum insulin concentrations and HOMA-IR, and
lower TC, TG, HDL-C and LDL-C concentrations than
white women, before and after adjusting for differences in
age and BMI. High-sensitivity CRP did not differ by race/
ethnicity (p = 0.9605), but after adjusting for age and BMI,
black women had higher hsCRP levels than white women
(p = 0.047). Black and white women also had similar sys-
tolic and diastolic blood pressure. Family history of T2D
(21.1 vs. 13.7%, p = 0.117) and CVD (25.8 vs. 24.2%, p = 0.
698) were not different between black and white women.
There were also significant racial/ethnic differences in SES
between the groups, such that the black women had lower
levels of education (p < 0.0001) and asset index (p < 0.
0001), and greater housing density (p < 0.0001) than white
women. Black women were less likely to smoke (p < 0.
0001) and drink alcohol (p < 0.0001), and more likely to
meet physical activity guidelines (p < 0.0001) than white
women. Approximately a third of the women reported
using contraceptives, with white women primarily using
oral contraceptives, and black women primarily using in-
jectable contraceptives.
Association between serum hsCRP and metabolic risk
factors, accounting for the potential effect of SES,
lifestyle factors and central adiposity
Based on the results of the bivariate associations between
the metabolic risk factors and the different SES and life-
style factors, multivariate linear regression models were
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used to examine the association between the metabolic risk
factors and hsCRP, adjusting for age, race/ethnicity and the
interaction between hsCRP and race/ethnicity (Model 1),
and accounting for SES and lifestyle factors (Model 2), and
WC (central adiposity) (Model 3). The truncated models
are presented in Table 3, with the full models presented as
supporting information (Additional file 1: Table S1,
Additional file 2: Table S2, Additional file 3: Table S3,
Additional file 4: Table S4, Additional file 5: Table S5).
High-sensitivity CRP was positively associated with
HOMA-IR in the combined sample of black and white
women (Model 1), independent of SES and lifestyle fac-
tors (Model 2). When further adjusting for WC, hsCRP
was no longer associated with HOMA-IR, but age was
inversely associated with HOMA-IR, whereas injectable
contraceptive use and WC were positively associated
with HOMA-IR (Model 3).
In contrast to HOMA-IR, there were race/ethnic-spe-
cific associations between hsCRP and serum lipid levels.
High-sensitivity CRP was associated with TG, independ-
ent of age (Model 1), SES, lifestyle factors (Model 2) and
WC (Model 3) in the white women only (Fig. 1, A1, A2
Table 1 General characteristics of sample population
Variables Black women (n = 194) White women (n = 153) p-value
Age (years) 24 (21–30) 31 (24–38) < 0.0001
Anthropometry
Height (m) 1.6 ± 0.1 1.7 ± 0.1 < 0.0001
Weight (cm) 74.9 (58.9–90.6) 69.3 (61.0–85.1) 0.5368
BMI (kg/m2) 30.4 (23.0–36.0) 24.5 (21.7–30.8) 0.0003
WC (cm) 86.5 (74.0–103.5) 85.0 (77.0–96.0) 0.6503
Blood pressure
Systolic blood pressure (mmHg) 101.5 (101.5–118.0) 102.5 (102.5–116.0) 0.523
Diastolic blood pressure (mmHg) 68.0 (68.0–80.5) 67.5 (67.5–81.5) 0.6211
SES factors
Education (%) < 0.0001
Have not completed high school 43.3 3.3
Completed high school 39.7 18.3
Tertiary education 17 78.4
Housing density (persons/room) 1.0 (0.6–1.5) 0.4 (0.3–0.6) < 0.0001
Asset index (amenities/house) 7.0 (5.0–10.0) 12.0 (11.0–14.0) < 0.0001
Lifestyle factors
Smoking status (%) < 0.0001
Current smoker 7.2 15.7
Ex-smoker 2.6 15.7
Non-smoker 90.2 68.6
Alcohol use (%) < 0.0001
Non-drinker 70.7 20.5
Moderate drinker 16 46.6
Heavy drinker 13.3 32.9
Physical activity (%) < 0.0001
Insufficiently active (< 150 min/week) 64.7 84
Sufficiently active (≥150 min/week) 35.3 16




Data presented as mean ± SD and median (interquartile range) or percentages. BMI body mass index, WC waist circumference, HOMA-IR homeostasis model of
insulin resistance, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, hsCRP high sensitivity
C-reactive protein
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and A3, respectively). There was also a race/ethnic-spe-
cific association between hsCRP and TC levels inde-
pendent of age (Model 1), such that hsCRP was
associated with higher TC in the white women, but
lower TC in the black women (Fig. 1, B1). These associa-
tions were independent of SES and lifestyle factors
(Model 2) for both black and white women (Fig. 1, B2).
When including WC in the model, the association be-
tween hsCRP and TC was no longer significant in the
white women, but the relationship remained in the black
women (Fig. 1, B3). In this model, higher age and higher
SES (represented by having completed high school) as
well as oral contraceptive use were associated with
higher TC levels. High-sensitivity CRP was also inversely
associated with HDL-C, independent of age (Model 1) in
the black women only (Fig. 1, C1). When adjusting for
SES and lifestyle factors, the inverse association between
hsCRP and HDL-C remained, but there was no longer a
significant interaction between hsCRP and race/ethnicity
(Model 2; Fig. 1, C2). In this model, higher SES (repre-
sented by having a tertiary education and lower housing
density), consuming less than one drink per day and oral
contraceptive use were associated with higher HDL-C
levels. Conversely, injectable contraceptive use was asso-
ciated with lower HDL-C levels. When including WC in
the model, hsCRP was no longer significantly associated
with HDL-C in the combined sample (Model 3), but the
relationship between hsCRP and HDL-C remained in
the black women. High-sensitivity CRP was positively as-
sociated with LDL-C levels, independent of age (Model
1), in the white women only (Fig. 1, D1). When includ-
ing SES and lifestyle factors in the model the relation-
ship between hsCRP and LDL-C remained, however
there was no longer an interaction between hsCRP and
race/ethnicity (Model 2). In this model, higher age,
completing high school and a higher housing density
were associated with higher LDL-C levels. Conversely,
consuming less that one alcoholic drink per day was
associated with lower LDL-C levels. When further add-
ing WC to the model, hsCRP was no longer significantly
associated with LDL-C levels (Model 3; Fig. 1, D3).
Discussion
In this cross-sectional study of apparently healthy, pre-
menopausal, South African women, we have shown that
black women have higher hsCRP levels when adjusted for
age and BMI, compared to white women. In addition,
hsCRP levels were significantly associated with HOMA-
IR, a measure of insulin resistance, and lipid levels in the
combined sample, however except for TG, this was not in-
dependent of central adiposity. The novel findings in this
study were that the association between hsCRP and the
lipid markers differed by race/ethnicity, and that SES and
lifestyle factors accounted for the association between
hsCRP and the lipoproteins (HDL-C and LDL-C), but not
for the association with TC and TG.
Our study corroborates the findings of other studies
that black women have higher hsCRP levels compared to
white women. Our study also lends support to the exist-
ing understanding that increased hsCRP is associated
with an adverse metabolic profile, including increased
HOMA-IR and a more atherogenic lipid profile, charac-
terized by higher TG, TC and LDL-C, and lower HDL-C
concentrations [14, 29]. Accordingly, hsCRP concentra-
tions seems a likely candidate to identify individuals at
increased metabolic risk. Therefore, based on our find-
ings, it could be assumed that the higher hsCRP in the
black women is associated with metabolic risk in this
population. However, we and others have consistently
shown that black women have a higher HOMA-IR [10,
11], but a more “favourable” lipid profile [7, 9], com-
pared to white women. Consequently, the association
between hsCRP and metabolic risk may be different in
persons of differing race/ethnicities. We further hypoth-
esized that these race/ethnic-specific associations could
be mediated, either directly or indirectly, by differences
Table 2 Unadjusted and age and BMI-adjusted blood-based metabolic risk factors of black and white South African women
Variables Unadjusted Adjusted values
Black women White women p-value Black women White women p-value
Glucose (mmol/l) 4.4 (4.1–4.8) 4.6 (4.4–4.9) 0.068 4.4 (4.3–4.6) 4.5 (4.5–4.7) 0.966
Insulin (mU/l) 8.0 (5.0–15.4) 6.1 (4.4–9.9) 0.0003 9.0 (6.5–12.4) 6.6 (5.0–8.7) < 0.0001
HOMA-IR (units) 1.6 (1.0–3.1) 1.2 (0.9–2.1) 0.006 1.8 (1.2–2.6) 1.4 (1.0–1.9) 0.0003
TC (mmol/l) 3.9 ± 0.8 4.7 ± 1.0 < 0.0001 3.8 ± 0.2 4.6 ± 0.2 < 0.0001
TG (mmol/l) 0.7 ± 0.3 0.9 ± 0.5 < 0.0001 0.7 ± 0.1 0.8 ± 0.1 < 0.0001
HDL-C (mmol/l) 1.3 ± 0.4 1.7 ± 0.4 < 0.0001 1.3 ± 0.2 1.6 ± 0.1 < 0.0001
LDL-C (mmol/l) 2.2 ± 0.7 2.6 ± 0.9 < 0.0001 2.1 ± 0.2 2.5 ± 0.2 < 0.0001
hsCRP (μg/ml) 2.3 (1.0–5.1) 2.3 (0.8–5.2) 0.9605 2.5 (1.1–3.9) 2.0 (1.4–3.3) 0.047
Data presented as mean ± SD or median (interquartile range). P-values are presented as unadjusted and adjusted for age and BMI. HOMA-IR homeostasis model of
insulin resistance, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, hsCRP high sensitivity
C-reactive protein
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in SES, lifestyle factors or central adiposity; factors
known to alter hsCRP levels and influence metabolic risk
and outcome [18]. Certainly, some studies have shown
that a higher inflammatory profile is linked to a lower
SES [20], as well as greater central body fat [30], both of
which are characteristic of black South African women.
Indeed, we found that higher hsCRP levels were asso-
ciated with higher levels of HOMA-IR in both racial/
ethnic groups, however despite hsCRP being associated
with a more atherogenic lipid profile, the relationship
differed by race/ethnicity, such that hsCRP was posi-
tively associated with TG and LDL-C in the white
women only, and inversely associated with HDL-C in
the black women only. An interesting finding in this
study, which has not been described before, was the in-
verse association between hsCRP and TC in the black
women, in direct contrast to the association found in
the white women. However, contrary to our hypothesis,
SES, lifestyle factors and central adiposity had no medi-
atory effect on the race/ethnic-specific relationship be-
tween hsCRP, TG and TC. Though the exact mechanism
underlying this disparate relationship is still unknown,
other lifestyle factors such as dietary intake, not mea-
sured in this study, might have had a more significant
Table 3 Adjusted associations between log-transformed metabolic risk factors, insulin resistance [HOMA-IR (units)] and serum lipids
(TG, TC, HDL-C and LDL-C (mmol/l)), and hsCRP (μg/ml) in black and white South African women
Variables Model 1 Model 2 Model 3
ln(HOMA-IR) β [95% CI] β [95% CI] β [95% CI]
hsCRP 0.09 [0.05; 0.13]** 0.10 [0.06; 0.14]** 0.03 [−0.01; 0.07]
Age −0.01 [− 0.02; 0.00] − 0.01 [− 0.02; 0.00] − 0.02 [− 0.03; − 0.01]**
Race/ethnicity 0.26 [0.03; 0.48]* 0.00 [− 0.27; 0.27] − 0.00 [− 0.23; 0.23]
hsCRPxrace/ethnicity − 0.02 [− 0.07; 0.04] −0.04 [− 0.09; 0.02] −0.02 [− 0.07; 0.02]
Adjusted-R2 0.11** 0.15** 0.38**
ln(TG) β [95% CI] β [95% CI] β [95% CI]
hsCRP 0.07 [0.05; 0.10]** 0.06 [0.04; 0.09]** 0.04 [0.02; 0.07]**
Age 0.01 [0.00; 0.01]* 0.01 [0.00; 0.02]* 0.01 [−0.00; −0.00]
Race/ethnicity −0.04 [− 0.18; 0.10] −0.14 [− 0.30; 0.03] −0.14 [− 0.30; 0.02]
hsCRPxrace/ethnicity − 0.05 [− 0.09; − 0.02]* −0.05 [− 0.08; − 0.01]* −0.04 [− 0.08; − 0.01]*
Adjusted-R2 0.18** 0.20** 0.26**
ln(TC) β [95% CI] β [95% CI] β [95% CI]
hsCRP 0.02 [0.01; 0.03]* 0.02 [0.00; 0.03]* 0.01 [−0.00; 0.02]
Age 0.00 [0.00; 0.01]* 0.01 [0.00; 0.01]** 0.01 [0.00; 0.01]**
Race/ethnicity −0.05 [− 0.11; 0.02] −0.04 [− 0.12; 0.03] −0.04 [− 0.12; 0.03]
hsCRPxrace/ethnicity − 0.04 [− 0.06; − 0.03]** −0.03 [− 0.05; − 0.02]** −0.03 [− 0.05; − 0.01]**
Adjusted-R2 0.26** 0.29** 0.30**
ln(HDL-C) β [95% CI] β [95% CI] β [95% CI]
hsCRP −0.01 [− 0.03; − 0.01]* −0.02 [− 0.03; − 0.00]* −0.00 [− 0.02; 0.01]
Age − 0.00 [− 0.01; 0.00] −0.00 [− 0.00; 0.00] 0.00 [− 0.00; 0.01]
Race/ethnicity −0.16 [− 0.25; − 0.07]** −0.01 [− 0.12; 0.09] −0.03 [− 0.13; 0.08]
hsCRPxrace/ethnicity − 0.03 [− 0.05; − 0.01]* −0.02 [− 0.04; 0.01] −0.02 [− 0.04; 0.00]
Adjusted-R2 0.22** 0.34** 0.39**
ln(LDL-C) β [95% CI] β [95% CI] β [95% CI]
hsCRP 0.03 [0.01; 0.05]* 0.02 [−0.00; 0.04]* 0.01 [−0.02; 0.03]
Age 0.01 [−0.00; 0.01] 0.01 [0.00; 0.12]* 0.01 [−0.00; 0.01]
Race/ethnicity −0.02 [− 0.14; 0.09] −0.14 [− 0.29; 0.01] −0.13 [− 0.27; 0.02]
hsCRPxrace/ethnicity − 0.04 [− 0.07; − 0.01]* −0.03 [− 0.06; 0.00] −0.03 [− 0.06; 0.00]
Adjusted-R2 0.08** 0.15** 0.19**
Data represents β-coefficients [95% confidence interval] and adjusted-R2. Model 1: hsCRP + age + race/ethnicity + (hsCRP x race/ethnicity interaction); Model 2:
(Model 1) + SES + lifestyle factors; Model 3: (Model 2) + WC. hsCRP, C-reactive protein; interaction term, interaction between hsCRP and race/ethnicity; ln(HOMA-IR),
ln(TG), natural log of triglycerides; natural log of homeostatic model assessment; ln(TC), natural log of total cholesterol; ln(HDL-C), natural log of high-density
lipoprotein cholesterol; ln(LDL-C), natural log of low-density lipoprotein cholesterol. *p < 0.05 and **p < 0.001
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race/ethnic-specific mediatory effect on the associ-
ation between hsCRP and lipid levels. Indeed, various
studies have reported a positive association between
inflammation and fatty acids, glucose, lipids, and an
inverse association with fibre, fruits, and vegetables
[31]. In the context of South Africa, the black popula-
tion have been shown to display an eating pattern
reflecting a higher consumption of fat and calories,
and lower consumption of fruits and vegetables [32].
Furthermore, previous studies have also shown a
stronger association between TG, TC and VAT depots
compared to SAT [33], because VAT is more
lipolytically active than SAT, owing to higher β-
adrenoreceptor-mediated catecholamine-induced lip-
olysis and greater resistance to the antilipolytic
activity of insulin [34]. Thus, the race/ethnic-specific
association might be mediated via abdominal fat de-
pots, as opposed to WC, which is a general measure
of central adiposity. This could also explain why
hsCRP was positively associated with TG and TC in
the white women, as white women have a greater ab-
dominal VAT depot compared to black women, who
Fig. 1 Adjusted association between log-transformed lipid markers and high-sensitivity C-reactive protein, for black and white South African women.
Data is presented as (1) predictive margins for white (blue line) and black (red line) women with 95% CI (shaded bands around predictive means) and
(2) the average marginal effect (dy/dx) for white and black women with p-value indicating association between hsCRP and lipid markers. Triglycerides
(TG) A1-A3; Total cholesterol (TC) B1-B3; high-density lipoprotein cholesterol (HDL-C) C1-C3; low-density lipoprotein cholesterol (LDL-C) D1-D3
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present with greater SAT [5, 6]. Further studies are
however needed to explore these race/ethnic-specific
associations in further detail.
In contrast, the race/ethnic-specific association be-
tween hsCRP and the lipoproteins (HDL-C and LDL-C)
were explained by racial/ethnic differences in SES, alco-
hol consumption and contraceptive use. Indeed, as
shown in other studies, we have shown that higher SES
[35], depicted by a higher level of education, and lower
housing density, as well as moderate alcohol use [36]
were associated with higher LDL-C and lower HDL-C
concentrations, independent of hsCRP. Within the
South African context, SES influences contraceptive use
[37], which we show here to be independently associated
with HDL-C levels. In our study, most of the black
women using contraceptives reported using injectable
contraceptives. These injectable contraceptives are most
likely the progestin-based injectable contraceptives
(depot medroxyprogesterone acetate), which has been
associated with a reduction in HDL-C [38]. Conversely,
oral contraceptives, predominantly used by the white
women in this study, have been associated with higher
HDL-C [39]. With that said, there is still a great need
for research to better understand what influences SES
and lifestyle factors have on inflammation within differ-
ent racial/ethnic groups.
Some limitations of this study must be considered. Firstly,
due to the cross-sectional nature of the study, data cannot
be used to investigate the causal relationship between
hsCRP and metabolic risk. Furthermore, this study has a
relatively small sample size and consists of a relatively
homogenous population of apparently healthy, predomin-
antly overweight and obese, premenopausal women, and
therefore it is not appropriate to generalize the findings to
the general population. Though we have studied a conveni-
ence sample, they are representative of the general black
and white South African adult female population, in terms
of the level of obesity [40]. Indeed, according to The South
African National Health and Nutrition Examination Survey
(SANHANES-1) the average BMI of South African women
is 28.9 kg/m2 and 39.2% of South African women are obese
[40]. Similarly, the average BMI found in our sample was
28.5 kg/m2 and 41.2% of the participants fall within the
obese range. However, our sample has a higher % of tertiary
educated individuals, as well as a higher rate of current
smokers and alcohol consumers, compared to the general
South African population [40]. The current study is also
limited to only hsCRP as a marker of inflammation, thus
additional markers such as TNF-α and IL-6 could be incor-
porated in future studies. In addition, only basic anthropo-
metric measures of body fatness and central adiposity were
used, but these have been shown to be as good as dual en-
ergy X-ray absorptiometry-derived measures of risk in this
population [41]. Furthermore, HOMA-IR was used as a
proxy for insulin resistance, but it has been validated
against a euglycaemic hyperinsulinamic clamp and proved
to be a reliable measure of insulin resistance in this popula-
tion [42]. Other limitations include, not measuring dietary
intake and nutrient composition.
Conclusions
This study highlights the significant relationship between
inflammation and increased metabolic risk in black and
white pre-menopausal South African women. Further-
more, despite the relationship between hsCRP and
HOMA-IR (a measure of insulin resistance) being inde-
pendent of race/ethnicity, SES and lifestyle factors, it is
not independent of central adiposity, supporting the
pivotal role of body fat distribution in metabolic risk.
For the first time we have shown that the association
between inflammation and lipids are race/ethnic-specific.
Therefore, although circulating hsCRP may identify indi-
viduals at increased metabolic risk, the heterogeneity in
these associations in black and white women highlights
the need for prospective studies investigating these asso-
ciations in different populations, as well as which factors
mediate or influence the relationship between inflamma-
tion and metabolic risk in different populations, in order
to design more effective interventions.
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